{"id":"W4411431344","doi":"10.1016/j.ard.2025.05.397","title":"LB0010 INHIBITION OF STRUCTURAL DAMAGE PROGRESSION WITH GUSELKUMAB, A SELECTIVE IL-23i, IN PARTICIPANTS WITH ACTIVE PsA: RESULTS THROUGH WEEK 24 OF THE PHASE 3b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED APEX STUDY","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Placebo; Randomized controlled trial; Internal medicine; Apex (geometry); Oncology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002731469,0.001027839,0.001864542,0.0003757711,0.0003701949,0.0008624011,0.0008347803,0.001026995,0.004778156],"category_scores_gemma":[0.001074504,0.000420124,0.001300933,0.000389423,0.0008312775,0.0008039821,0.0004079078,0.003281244,0.001146252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004971315,"about_ca_system_score_gemma":0.001472141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005137268,"about_ca_topic_score_gemma":0.001715154,"domain_scores_codex":[0.9993029,0.0003119834,0.00005580963,0.00008781401,0.0001379537,0.0001036134],"domain_scores_gemma":[0.9990181,0.000162509,0.0002739509,0.00006193815,0.0001038905,0.000379722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8481565,0.04755998,0.004186369,0.001152365,0.001095087,0.00007675531,0.0001506284,0.0005238535,0.03506015,0.0001147583,0.002517747,0.05940578],"study_design_scores_gemma":[0.4988303,0.4771727,0.01653877,0.00006805065,0.0008376493,0.0001017787,0.00006548556,0.0004834759,0.004000217,0.0001368941,0.001734784,0.00002987926],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892287,0.004398958,0.0006396775,0.000470113,0.0001536481,0.001900459,0.001558423,0.0001230969,0.001526938],"genre_scores_gemma":[0.9894995,0.002485821,0.001424208,0.0007769688,0.0002844698,0.001845464,0.001602613,0.0000373919,0.00204344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004778156,"threshold_uncertainty_score":0.01598448,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06337347291886843,"score_gpt":0.4002863555902518,"score_spread":0.3369128826713834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}